HEPATITIS CAUSED BY THE NEWER AMINE-OXIDASE-INHIBITING DRUGS
- 1 September 1961
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 278 (7203) , 621-623
- https://doi.org/10.1016/s0140-6736(61)90306-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Trial a New Monoamine Oxidase Inhibitor in Angina PectorisBMJ, 1960
- Hepatocellular Jaundice as a Complication of Iproniazid TherapyArchives of internal medicine (1960), 1960
- FATAL JAUNDICE AFTER ADMINISTRATION OF BETA-PHENYLISOPROPYLHYDRAZINEJAMA, 1959
- SERIAL HEPATIC STUDY IN PATIENTS TREATED WITH IPRONIAZIDAnnals of the New York Academy of Sciences, 1959
- EXPERIMENTAL PATHOLOGY OF IPRONIAZID AND RELATED COMPOUNDSAnnals of the New York Academy of Sciences, 1959
- THE EFFECTS OF IPRONIAZID AND OTHER AMINE OXIDASE INHIBITORS IN RHEUMATOID ARTHRITISAnnals of the New York Academy of Sciences, 1959
- ACUTE HEPATIC NECROSIS FOLLOWING IPRONIAZID THERAPYThe Lancet, 1959
- PATHOLOGICAL FINDINGS IN JAUNDICE ASSOCIATED WITH IPRONIAZID THERAPYJAMA, 1958
- Use of Iproniazid in Ischaemic Angina PectorisBMJ, 1958